APA (7th ed.) Citation

A, T., C, S., A, S., A, C., L, B., E, D., . . . L, G. (2024). Effectiveness of 8-week Treatment with Glecaprevir/Pibrentasvir in Treatment-naïve or -experienced HCV Patients: Results from an Observational Retrospective Study in Real-life Settings (ODYSSEY). Journal of gastrointestinal and liver diseases : JGLD, 33(4), 503. https://doi.org/10.15403/jgld-5745

Chicago Style (17th ed.) Citation

A, Trifan, et al. "Effectiveness of 8-week Treatment with Glecaprevir/Pibrentasvir in Treatment-naïve or -experienced HCV Patients: Results from an Observational Retrospective Study in Real-life Settings (ODYSSEY)." Journal of Gastrointestinal and Liver Diseases : JGLD 33, no. 4 (2024): 503. https://doi.org/10.15403/jgld-5745.

MLA (9th ed.) Citation

A, Trifan, et al. "Effectiveness of 8-week Treatment with Glecaprevir/Pibrentasvir in Treatment-naïve or -experienced HCV Patients: Results from an Observational Retrospective Study in Real-life Settings (ODYSSEY)." Journal of Gastrointestinal and Liver Diseases : JGLD, vol. 33, no. 4, 2024, p. 503, https://doi.org/10.15403/jgld-5745.